The inflammatory response plays a role of the ATR-induced cardiac damage. ATR induces cardiac damage via enhancing the NO production. LYC shows the chemoprotective potential against ATR-induced cardiac damage. LYC alleviates ATR-induced cardiac damage via modulating NO-generating systems. LYC mitigates ATR-induced cardiac damage via blocking the TRAF6-NF-κB pathway.